Astellas Pharma Us recalls

Astellas Pharma Us appears in 5 official U.S. recall notices indexed by RecallRadar, most recently on 2025-02-05.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbro…
  FDA Drug · Class I · 2025-02-05 · Astellas Pharma Us
• Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US…
  FDA Drug · Class I · 2025-02-05 · Astellas Pharma Us
• Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc
  FDA Drug · Class II · 2018-02-14 · Astellas Pharma Us
• Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc
  FDA Drug · Class II · 2014-10-15 · Astellas Pharma Us
• AmBisome (amphotericin B) liposome for injection, 50mg vial, single use vial, For Intravenous Infusion Only, Rx Only, Marketed by: Astellas…
  FDA Drug · Class II · 2013-07-31 · Astellas Pharma Us